Vaccination Status – Page 8 – Communicable Diseases Research

Vaccination status among patients with the need for emergency hospitalizations related to COVID-19

코로나19 관련 긴급 입원이 필요한 환자의 예방접종 현황

Article

Published on 2022-04-012022-09-11
Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 변종,

Characteristics, Vaccination Status and Outcomes Among Healthy Younger Adults in a Large Public Healthcare System in the South Florida Region

플로리다 남부 지역의 대규모 공공 의료 시스템에서 건강한 젊은 성인의 특성, 예방 접종 상태 및 결과

Article

Published on 2022-04-012022-09-11
Journal: Journal of community health [Category] COVID19(2023년), SARS, 변종,

[키워드] Adults age Characteristics clinically COVID-19 COVID-19 disease COVID-19 illness death delta variant Descriptive analysis dominant dose ECMO effort healthy high risk history of smoking Hospitalization Hospitalized Infectious disease laboratory-confirmed Laboratory-confirmed COVID-19 less Memorial occurred old age Older outcome Patient patients pregnant female proportion provide Public readmission Region reported retrospective risk of COVID-19 Risk perception SARS-CoV-2 severe COVID-19 severe COVID-19 disease severe COVID-19 illness smoking South status stratified study population System the vaccine underlying condition underlying conditions vaccination Vaccination Status ventilator with COVID-19 young adults
[DOI] 10.1007/s10900-022-01062-y PMC 바로가기 [Article Type] Article

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis

변종 및 예방접종 현황에 따른 SARS-CoV-2의 가구 2차 공격 비율: 업데이트된 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2022-04-012022-09-11
Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% CI 95% CIs affected Alpha article articles attack attack rate Beta changed changes in Contact covariate covariates COVID-19 Delta effective vaccine Effective vaccines Effectiveness eligible evaluate household household contacts household SAR Household SARs index case Infection infection rate infectiousness item linear mixed model meta-analyses number of household number of infected omicron outcome Probability Rate reductions reductions in reported Reporting review SAR SAR estimate SARS-CoV-2 SARS-CoV-2 variant secondary secondary attack rate Secondary infection stratified susceptibility susceptibility to infection synthesis systematic reviews Transmissibility Transmission transmission rates vaccination Vaccination Status Vaccine variant variants of concern viral evolution viral variant were used
[DOI] 10.1001/jamanetworkopen.2022.9317 PMC 바로가기 [Article Type] Meta-Analysis

Clinical Characteristics of COVID-19 Patients’ Postvaccination

코로나19 환자의 예방접종 후 임상적 특징

Article

Published on 2022-04-012022-09-11
Journal: Viral immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed approaches characteristic China clinical clinical characteristic Clinical characteristics collected Computed tomography conducted coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients CT findings demographic and clinical characteristics group groups IgG IgG antibodies IgG antibody IgG levels IgM implementation Infection information Laboratory no significant differences not affect not altered nucleic acid other variables outcome Patient respiratory SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 nucleic acid second dose severe acute respiratory syndrome Coronavirus significant difference temperature the median therapeutic approaches Thoracic Underscore vaccination Vaccination Status Vaccine vaccine dose Viral viral shedding
[DOI] 10.1089/vim.2021.0204 PMC 바로가기 [Article Type] Article

Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US

미국에서 백신 접종을 하지 않은 가족 중 단클론 항체를 사용한 COVID-19 예방의 예상 건강 결과 및 비용

Randomized Controlled Trial

Published on 2022-04-012022-09-11
Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, 임상, 진단,

[키워드] Administered age Casirivimab complementary confirmed COVID-19 case Contact Coverage COVID-19 COVID-19 case COVID-19 infection COVID-19 infections COVID-19 pandemic COVID-19 vaccination death deaths disrupt effective vaccine Effective vaccines eligible Estimated Ethnicity exposure to Health health system Hospitalization hospitalizations household household contact Imdevimab IMPROVE individual Infection intensity mAb mAbs monoclonal antibodies monoclonal antibody Older outcome Postexposure Prophylaxis Probability public health randomized clinical trial reduce reduce costs Sex subcutaneous injection subcutaneous injections susceptible symptomatic infection symptomatic infections threshold thresholds Transmission Vaccination Status Vaccine variant of SARS-CoV-2
[DOI] 10.1001/jamanetworkopen.2022.8632 PMC 바로가기 [Article Type] Randomized Controlled Trial

Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines

중증급성호흡기증후군 코로나바이러스 2 벡터 및 mRNA 기반 백신 접종 후 3차 병원 직원 중 접종 후 감염

Observational Study

Published on 2022-04-012022-09-11
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, 임상,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration Alpha variant analysed Antigen B.1.1.7 B.1.351 B.1.617.2 Beta Beta variant BNT162b2 Breakthrough infection breakthrough infections Care ChAdOx1 ChAdOx1-S cohort study coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death defined Delta delta variant demographic data dose effective first dose follow-up period hazard ratio hazard ratios hospital Hospital employees Hospitalization incidence Infection mRNA mRNA-based vaccine mRNA-based vaccine. not differ Observational cohort study Participants positive PCR positive PCR test postvaccination Postvaccination infection reported respiratory specimen retrospective retrospective observational cohort study RNA SARS-CoV-2 SARS-CoV-2 vaccine second dose severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specimen vaccination Vaccination Status Vaccine vaccine dose vaccine doses variant Vector-based vaccine Viral load virus variants
[DOI] 10.1016/j.cmi.2021.11.023 PMC 바로가기 [Article Type] Observational Study

BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era

델타 시대 스코틀랜드에서 BNT162b2 및 ChAdOx1 nCoV-19 예방 접종, SARS-CoV-2 감염 및 COVID-19 입원 발생

Article

Published on 2022-03-262022-09-11
Journal: Journal of Global Health [Category] SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age association B.1.617.2 BNT162b2 ChAdOx1 ChAdOx1 nCoV-19 cohort analysis comparable condition coronavirus Coverage COVID-19 COVID-19 hospitalisation defined Delta delta variant dominant dose enhanced Follow-up group Hospital admission Hospital admissions hospitalisation hospitalisations hospitalised incidence incidence rate incidence rates individuals Infection much lower National Older age outcomes performed platform population level positive reduction in SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections severe acute respiratory syndrome Coronavirus severe COVID-19 stratified the SARS-CoV-2 vaccination Vaccination Status Vaccinations Vaccine
[DOI] 10.7189/jogh.12.05008 PMC 바로가기 [Article Type] Article

COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status – COVID-NET, 14 States, July 2021-January 2022

인종/민족 및 예방 접종 상태별 SARS-CoV-2 Delta 및 Omicron 변종 우세 기간 동안 성인 중 COVID-19 관련 입원 - COVID-NET, 14개 주, 2021년 7월-2022년 1월

Article

Published on 2022-03-252022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종,

Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients

Original Article

Published on 2022-03-232022-10-04
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 바이오마커, 진단,

[키워드] 95% CI Abstract acute infection association conducted COVID-19 COVID-19 vaccination disease onset domain humoral Humoral response Hybrid immunity IgG Image interquartile range Long COVID-19 median natural immunity natural infection no significant difference objective Occurrence Outpatient Patient patients persistence Post–COVID-19 Post–COVID-19 Prospective Study RBD response to vaccination Result SARS Coronavirus SARS-CoV-2 antibodies SARS-CoV-2 IgG SARS-CoV-2 serology SARS-CoV-2 vaccination serological Serological assay significantly higher Symptom syndrome titre unvaccinated Vaccinated vaccination Vaccination Status with COVID-19 without symptom worsening
[DOI] 10.1016/j.cmi.2022.03.016 PMC 바로가기 [Article Type] Original Article

Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE)

Sinopharm의 BBIBP-CorV 백신이 감염된 백신의 입원 및 사망 예방에 미치는 영향: 아랍에미리트(UAE) 아부다비 토후국에서 실시한 후향적 연구 결과

Observational Study

Published on 2022-03-182022-09-11
Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, 임상,

[키워드] Abu Admissions BBIBP-CorV Care conducted COVID-19 COVID-19 pandemic COVID-19-related admission Critical Critical care death Department determine doses effective Effectiveness Emirate explained Factor group hospital Hospital admission Hospital admissions Impact Inactivated vaccine Inactivated viral vaccine incidence incidence density incidence rate individual individuals neutralizing antibody responses observational study outcome participant PCR-positive per 1000 person-years positive positive status Real-world vaccine effectiveness study Reinfection reported Result retrospective Retrospective study SARS-CoV-2 selected Seroconversion severe disease single dose Sinopharm Sinopharm BBIBP-CorV vaccine statistically study outcomes Study participants the vaccine three group three groups two-dose regimen United Arab Emirate United Arab Emirates United Arab Emirates (UAE). vaccinated individual vaccination Vaccination Status Vaccine variants were excluded
[DOI] 10.1016/j.vaccine.2022.02.039 PMC 바로가기 [Article Type] Observational Study